Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Less antitrust scrutiny under Trump boosts M&A confidenceHealthcare M&A volume rose 56% in 2025, despite fewer transactionsJPMorgan health…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Item 1 of 2 Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White…